Back to search

Article

Prevalence and global trends of polypharmacy in patients with chronic Liver disease: a systematic review and meta-analysis

2022-07-14

Abstract excerpt

<title>Abstract</title> <p>Background despite its central role in drug metabolism the exact prevalence estimates and factors impacting on the global trends of polypharmacy in patients with chronic liver disease has remained unexamined. Methods We carried a comprehensive search of relevant databases (PubMed; EMBASE, Science citation index Cochrane Database of Systematic Reviews; and database of abstracts of revi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
aaa6e89e-bcaa-5a43-9116-634f3e2fd387
DOI
10.21203/rs.3.rs-1829699/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prevalence and global trends of polypharmacy in patients with chronic Liver disease: a systematic review and meta-analysisDOI 10.21203/rs.3.rs-1829699/v1
The Impact of Polypharmacy Therapeutic classes on Mortality Outcomes in Patients with Chronic Liver DiseaseSemantic proximity
Prevalence and Global Factors Influencing Polypharmacy and its Clinical Phenotypes in Cancer Patients: A Systematic Review and Meta-AnalysisSemantic proximity
Epidemiology, temporal trends, and fibrosis risk stratification in metabolic dysfunction-associated steatotic liver disease in UK primary care: a population-based cohort and nested case-control studySemantic proximity
High incidence of hepatocarcinoma in patients with advanced fibrosis treated with direct-acting antiviral agents for hepatitis C: A real-world retrospective study.Semantic proximity
The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction–associated steatotic liver disease and alcohol-associated liver diseaseSemantic proximity
Association of Antihypertensive Medication and Steatotic Liver Disease with Liver Fibrosis and Mortality among US AdultsSemantic proximity
Polypharmacy and potentially inappropriate medications in older adults who use long-term care services: A cross-sectional studySemantic proximity
Screening program in healthy individuals reveals a high prevalence of chronic hepatitis C in the general population of AustriaSemantic proximity
Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey.Semantic proximity
Impact of Egypt’s Hepatitis C Elimination Program on Liver Cancer Burden with Projections to 2050Semantic proximity
Polypharmacy, cardiovascular-specific medication use, and comorbidity burden among elderly residents in care homes of Colombo District, Sri Lanka: A cross-sectional studySemantic proximity
Prevalences and healthcare expenditures related to 58 health conditions from 2012 to 2017 in France: diseases and healthcare expenditure mapping, a national population-based studySemantic proximity
Select a neighboring publication to make it the new centre.